BRIM Biotechnology Inc.

Quick facts

Phase 3 pipeline

• BRM421 Ophthalmic Solution · Ophthalmology
  BRM421 is an ophthalmic solution designed to treat ocular surface disease, likely through anti-inflammatory or lubricating mechanisms.

Phase 2 pipeline

• BRM421
• BRM421 Ophthalmic Solution, 0.03%
• BRM421 Ophthalmic Solution, 0.06%
• BRM424 Ophthalmic Solution - Dose1 · Ophthalmology
  BRM424 Ophthalmic Solution is a topical anti-inflammatory agent.